Low molecular weight heparins for current and future uses: approaches for micro- and nano-particulate delivery
- 9 June 2015
- journal article
- review article
- Published by Taylor & Francis in Drug Delivery
- Vol. 23 (8) , 2661-2667
Abstract
Low molecular weight heparins (LMWHs), the anticoagulant drug of choice in many indications, had been suggested as novel drug treatment for a range of diseases. Their superior pharmacokinetic properties compared to unfractionated heparin (UFH), motivated scientists to explore new delivery systems for improved therapeutic outcomes. Micro- and nano-carriers, with the versatile nature and characteristics of materials used for their fabrication, are able to surmount the challenges opposed by their native structures. The present review discusses the recent perspectives on the development of micro- and nano-particulate vectors for the delivery of LMWHs through various routes. Special focus on the application of the suggested systems, their characterization and the achieved improved bioavailability will be given throughout the review.Keywords
This publication has 60 references indexed in Scilit:
- Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue EngineeringInternational Journal of Molecular Sciences, 2013
- Parenteral AnticoagulantsChest, 2012
- Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug deliveryAdvanced Drug Delivery Reviews, 2011
- Recent advances in search of oral heparin therapeuticsMedicinal Research Reviews, 2011
- Cationic liposomes as carriers for aerosolized formulations of an anionic drug: Safety and efficacy studyEuropean Journal of Pharmaceutical Sciences, 2009
- Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluationJournal of Controlled Release, 2008
- The quest for non-invasive delivery of bioactive macromolecules: A focus on heparinsJournal of Controlled Release, 2006
- Low-Molecular-Weight Heparin-Conjugated Liposomes with Improved Stability and HemocompatibilityDrug Delivery, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976